OGT 2115

Overview

OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC 50 of 0.4 μM. OGT 2115 has anti-angiogenic properties ( IC 50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Glycosidase

Product Information

• Catalog No.: HY-100898
• CAS No.: 853929-59-6
• Molecular Formula: C24H16BrFN2O4
• Molecular Weight: 495.30
• Purity: 99.58%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (2.02 mM); Clear solution
• Availability: In-stock

Source

Original product source